NCT02127866 - Triple in Asthma Dose Finding | Biotech Hunter

Enrollment

211

Participants

Timeline

Start Date

April 30, 2014

Primary Completion Date

March 31, 2015

Study Completion Date

March 31, 2015

Conditions

Asthma

Interventions

DRUG

CHF 5259 plus Foster 100/6 µg

Comparison of different doses of CHF 5259 (on top of Foster 100 /6 µg) versus Foster 100/6 µg over a treatment period of 6 weeks. Each subject will be allocated to 3 ouf of the 4 possible treatments performed in sequence during a cross over design (incomplete block)

DRUG

Foster 100/6 µg

"Active comparator~Comparison of different doses of CHF 5259 (on top of Foster 100 /6 µg) versus Foster 100/6 µg over a treatment period of 6 weeks. Each subject will be allocated to 3 ouf of the 4 possible treatments performed in sequence during a cross over design (incomplete block)"

Trial Locations (44)

1122

Chiesi Clinical Trial Site 0302, Budapest

1233

Chiesi Clinical Trial Site 0107, Sofia

1336

Chiesi Clinical Trial Site 0108, Sofia

1407

Chiesi Clinical Trial Site 0102, Sofia

1431

Chiesi Clinical Trial Site 0110, Sofia

1432

Chiesi Clinical Trial Site 0109, Sofia

2100

Chiesi Clinical Trial Site 0305, Gödöllő

2600

Chiesi Clinical Trial Site 0105, Dupnitsa

2660

Chiesi Clinical Trial Site 0307, Balassagyarmat

2900

Chiesi Clinical Trial Site 0303, Komárom

5400

Chiesi Clinical Trial Site 0106, Sevlievo

5540

Chiesi Clinical Trial Site 0306, Szarvas

5600

Chiesi Clinical Trial Site 0104, Troyan Municipality

6003

Chiesi Clinical Trial Site 0103, Stara Zagora

6772

Chiesi Clinical Trial Site 0304, Deszk

7002

Chiesi Clinical Trial Site 0101, Rousse

8600

Chiesi Clinical Trial Site 0301, Siófok

10787

Chiesi Clinical Trial Site 0208, Berlin

12165

Chiesi Clinical Trial Site 0207, Berlin

22927

Chiesi Clinical Trial Site 0206, Großhansdorf

23552

Chiesi Clinical Trial Site 0203, Lübeck

25123

Chiesi Clinical Trial Site 0403, Brescia

34149

Chiesi Clinical Trial Site 0408, Trieste

37134

Chiesi Clinical Trial Site 0404, Verona

39112

Chiesi Clinical Trial Site 0202, Magdeburg

43125

Chiesi Clinical Trial Site 0402, Parma

56124

Chiesi Clinical Trial Site 0401, Pisa

58452

Chiesi Clinical Trial Site 0210, Witten

04357

Chiesi Clinical Trial Site 0201, Leipzig

01445

Chiesi Clinical Trial Site 0204, Radebeul

15-430

Chiesi Clinical Trial Site 0510, Bialystok

80-847

Chiesi Clinical Trial Site 0507, Gdansk

11-500

Chiesi Clinical Trial Site 0502, Giżycko

31-637

Chiesi Clinical Trial Site 0511, Krakow

90-141

Chiesi Clinical Trial Site 0505, Lodz

90-153

Chiesi Clinical Trial Site 0509, Lodz

20-718

Chiesi Clinical Trial Site 0512, Lublin

14-100

Chiesi Clinical Trial Site 0503, Ostróda

32-600

Chiesi Clinical Trial Site 0501, Oświęcim

32-100

Chiesi Clinical Trial Site 0506, Proszowice

35-241

Chiesi Clinical Trial Site 0508, Rzeszów

51-162

Chiesi Clinical Trial Site 0504, Wroclaw

W1G 8HU

Chiesi Clinical Trial Site 0602, London

M23 9QZ

Chiesi Clinical Trial Site 0601, Manchester

All Listed Sponsors

lead

Chiesi Farmaceutici S.p.A.

INDUSTRY